Xlumena is the leader in developing products that enable advanced image-guided endoscopy procedures. These innovations will allow endoscopists to offer minimally invasive alternatives to patients suffering from common gastrointestinal and biliary conditions. Pioneering interventional endoscopists around the world are using Xlumena's products to extend their therapeutic reach.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/03/13 | $25,000,000 | Series C |
Aperture Venture Partners Third Point Ventures | undisclosed |
